Treace Medical Concepts (TMCI) Operating Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Operating Expenses for 7 consecutive years, with $50.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 7.6% year-over-year to $50.6 million; the trailing twelve-month figure through Jun 2026 stood at $216.8 million (down 1.05% YoY), and the FY2025 full-year result was $223.9 million, changed 0.02% from the prior year.
• Operating Expenses eased to $50.6 million in Q2 2026 per TMCI's latest filing, from $54.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $59.9 million in Q1 2024 and bottomed at $32.0 million in Q1 2022.
• Historically, Operating Expenses has averaged $50.4 million across 5 years, with a median of $52.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Operating Expenses soared 90.76% in 2022, then slipped 7.6% in 2026.
• Over 5 years, Operating Expenses stood at $44.2 million in 2022, then jumped by 30.01% to $57.5 million in 2023, then declined by 3.21% to $55.7 million in 2024, then increased by 1.15% to $56.3 million in 2025, then declined by 10.22% to $50.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $50.6 million, $54.6 million, and $56.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.